Welcome to our dedicated page for Microchip Technology SEC filings (Ticker: MCHP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Microchip Technology Inc. filings document operating results, material events, governance matters, and capital-structure disclosures for a public semiconductor company. Form 8-K reports include quarterly and annual results, financial-condition exhibits, material-event disclosures, material agreements, and securities information for common stock and depositary shares representing interests in 7.50% Series A Mandatory Convertible Preferred Stock.
Proxy and annual meeting filings cover board elections, auditor ratification, executive compensation, shareholder voting matters, and related governance disclosures. The company’s regulatory record also provides formal disclosure on security listings, stockholder approvals, and the corporate actions and risk topics associated with its semiconductor product portfolio and public-company obligations.
Microchip Technology (MCHP) senior vice president of worldwide client engagement reported routine equity transactions related to restricted stock units. On November 15, 2025, multiple restricted stock unit (RSU) awards with an exercise price of $51.7 per share were converted to common stock, with 338, 786, and later on November 17, 2025, 393 RSUs settling into shares. Some of the resulting shares, including 145, 337, and 169 shares, were withheld and disposed of using transaction code "F" at $51.7 per share, which typically reflects tax withholding on vested equity.
Following these transactions, the reporting person directly owned 17,181 shares of Microchip Technology common stock.
Microchip Technology Incorporated (MCHP) senior vice president of operations reported multiple equity award vesting events and related share withholding transactions. On November 15, 2025, restricted stock units and performance stock units converted into common stock in several tranches, including 870, 840, and 1,465 shares at an exercise price of $51.7 per share, with portions of 243, 234, and 409 shares withheld, coded as dispositions for tax purposes. Additional performance stock units and restricted stock units covering 238 and 452 shares vested on November 17, 2025, with 67 and 126 shares withheld. After these transactions, the officer directly owned 32,522 shares of Microchip common stock.
Microchip Technology (MCHP) Senior VP and CFO, reporting as an indirect owner via a trust, disclosed multiple equity award settlements on November 15 and 17, 2025. Restricted stock units and performance stock units converted into common stock at an exercise price of $51.7 per share, shown as transaction code “M” in both the non-derivative and derivative tables.
Shares were delivered to the executive as the awards vested, while some shares (code “F”) were withheld to cover obligations, leaving 34,381 shares of common stock beneficially owned indirectly by the trust after the final reported transaction. The PSUs are tied to Microchip’s cumulative non-GAAP operating margin targets over 12-quarter periods ending on September 30, 2024 and September 30, 2025, reflecting performance-based compensation.
Microchip Technology (MCHP) reported an insider equity grant by its Chief Operating Officer. On November 6, 2025, the reporting person acquired 846 restricted stock units (RSUs), each representing the right to receive one share of common stock. The RSUs vest in full on November 15, 2026, contingent on continued service. Following the transactions, the filer reported 151,057 shares of common stock held indirectly by a trust, and 846 RSUs held directly.
Microchip Technology (MCHP) insider filed a Form 4 reporting equity awards and holdings. On 11/06/2025, the reporting person received 7,940 restricted stock units (RSUs), each representing one share of common stock, at a stated price of $0. These RSUs vest in full on May 15, 2028, contingent on continued service.
Following the reported transactions, 10,167,682 shares of common stock were beneficially owned indirectly, including 4,261,810 shares held by The Sanghi Trust and 5,905,872 shares held by The Sanghi Family Limited Partnership. The person also held 7,940 derivative securities (RSUs) directly after the award.
Microchip Technology (MCHP) insider filing: the company’s Sr. VP, WW Client Engagement reported the acquisition of 481 restricted stock units (RSUs) on 11/06/2025 (Form 4). Each RSU equals one share of common stock.
The RSUs vest in full on November 15, 2026, subject to continued service. After the reported transactions, the reporting person beneficially owned 16,315 shares of Microchip common stock, held directly.
Microchip Technology (MCHP) Form 4: A Senior VP, Operations reported an award of 460 restricted stock units on 11/06/2025. Each RSU represents the right to receive one share of common stock and will vest in full on November 15, 2026, subject to continued service through that date. Following the reported transaction, the reporting person directly owned 29,736 shares of Microchip Technology common stock.
Microchip Technology (MCHP) reported an insider equity award for its Senior VP and CFO. On 11/06/2025, the executive acquired 634 restricted stock units (RSUs) at a price of $0 under a Form 4 filing.
The RSUs will vest in full on November 15, 2026, with shares delivered upon vesting. Following the reported transactions, the executive beneficially owned 634 derivative securities directly and 30,089 shares of common stock indirectly through a trust.
Microchip Technology (MCHP) filed its quarterly report for the period ended September 30, 2025. Net sales were $1,140.4 million versus $1,163.8 million a year ago, with gross profit of $637.9 million. Operating income was $88.9 million, down from $146.6 million. Net income was $41.7 million; after $27.8 million of Series A preferred dividends, net income attributable to common stockholders was $13.9 million, or $0.03 per diluted share, versus $0.14 a year ago.
For the first six months, net sales were $2,215.9 million versus $2,405.1 million, and operating income was $121.0 million versus $365.7 million. Operating cash flow was $363.7 million. Cash and cash equivalents were $236.8 million, down from $771.7 million at March 31, 2025. The company settled $1.2 billion of 4.250% 2025 notes in September using Commercial Paper and cash; Commercial Paper outstanding was $1.12 billion. Deferred revenue was $385.8 million, including $291.5 million of LTSA deposits. The company paid a $0.455 per‑share common dividend and $27.8 million on its 7.50% Series A preferred, and disclosed an IRS settlement for fiscal years 2007–2015.
Microchip Technology (MCHP) filed its quarterly report for the period ended September 30, 2025. Net sales were $1,140.4 million versus $1,163.8 million a year ago, with gross profit of $637.9 million. Operating income was $88.9 million, down from $146.6 million. Net income was $41.7 million; after $27.8 million of Series A preferred dividends, net income attributable to common stockholders was $13.9 million, or $0.03 per diluted share, versus $0.14 a year ago.
For the first six months, net sales were $2,215.9 million versus $2,405.1 million, and operating income was $121.0 million versus $365.7 million. Operating cash flow was $363.7 million. Cash and cash equivalents were $236.8 million, down from $771.7 million at March 31, 2025. The company settled $1.2 billion of 4.250% 2025 notes in September using Commercial Paper and cash; Commercial Paper outstanding was $1.12 billion. Deferred revenue was $385.8 million, including $291.5 million of LTSA deposits. The company paid a $0.455 per‑share common dividend and $27.8 million on its 7.50% Series A preferred, and disclosed an IRS settlement for fiscal years 2007–2015.
Microchip Technology (MCHP) filed its quarterly report for the period ended September 30, 2025. Net sales were $1,140.4 million versus $1,163.8 million a year ago, with gross profit of $637.9 million. Operating income was $88.9 million, down from $146.6 million. Net income was $41.7 million; after $27.8 million of Series A preferred dividends, net income attributable to common stockholders was $13.9 million, or $0.03 per diluted share, versus $0.14 a year ago.
For the first six months, net sales were $2,215.9 million versus $2,405.1 million, and operating income was $121.0 million versus $365.7 million. Operating cash flow was $363.7 million. Cash and cash equivalents were $236.8 million, down from $771.7 million at March 31, 2025. The company settled $1.2 billion of 4.250% 2025 notes in September using Commercial Paper and cash; Commercial Paper outstanding was $1.12 billion. Deferred revenue was $385.8 million, including $291.5 million of LTSA deposits. The company paid a $0.455 per‑share common dividend and $27.8 million on its 7.50% Series A preferred, and disclosed an IRS settlement for fiscal years 2007–2015.
Microchip Technology Incorporated furnished an 8‑K to announce its results of operations for the second quarter of fiscal year 2026. The disclosure was provided under Item 2.02 (Results of Operations and Financial Condition) and, as stated, is being furnished pursuant to General Instruction B(2) and is not deemed filed under Section 18 of the Exchange Act.
The company attached a press release as Exhibit 99.1 titled “Microchip Technology Announces Financial Results for Second Quarter of Fiscal Year 2026.”
Microchip Technology Incorporated furnished an 8‑K to announce its results of operations for the second quarter of fiscal year 2026. The disclosure was provided under Item 2.02 (Results of Operations and Financial Condition) and, as stated, is being furnished pursuant to General Instruction B(2) and is not deemed filed under Section 18 of the Exchange Act.
The company attached a press release as Exhibit 99.1 titled “Microchip Technology Announces Financial Results for Second Quarter of Fiscal Year 2026.”
Microchip Technology Incorporated furnished an 8‑K to announce its results of operations for the second quarter of fiscal year 2026. The disclosure was provided under Item 2.02 (Results of Operations and Financial Condition) and, as stated, is being furnished pursuant to General Instruction B(2) and is not deemed filed under Section 18 of the Exchange Act.
The company attached a press release as Exhibit 99.1 titled “Microchip Technology Announces Financial Results for Second Quarter of Fiscal Year 2026.”